Anti-tumor activity was demonstrated with IL-13-PE in an immunodeficient xenograft mouse model using these human HNSCC cell lines and the immunotoxin treatment were well-tolerated by the mice [10]. Here, IL13 is linked to head and neck squamous cell carcinoma.